RJW & Partners consolidates senior level expertise with latest appointment
Publication date: 12 August 2010
Author: Limewash Media & Design
Tagged with: Natalie Shalet, Neil Johnson, RJW & Partners
Pricing and market access consultants to the pharmaceutical and medical device industries, RJW & Partners, are delighted to announce the appointment of Natalie Shalet as Senior Consultant, strengthening the pricing and market access capability within the firm.
Natalie Shalet
Natalie has over 10 years experience in the pharmaceutical and consulting industry and brings a broad knowledge of strategic pricing and market access consulting, business development, finance and clinical trial management to the team at RJW & Partners. She joins from Kantar Health (formerly MattsonJack), where as Director of Pricing and Market Access, Natalie developed new business and delivered project work for global pharmaceutical clients working in a range of therapy areas including, oncology, cardiovascular, diabetes, cholesterol management, bone marrow transplantation and pain.
Natalie began her industry career in clinical research at Theradex before moving into corporate finance and deal evaluation (mergers and acquisitions, IPO due diligence) in the Life Sciences division at WestLB Panmure. From there she moved to IMS Health to work as a Senior Consultant in client analysis and engagement, developing new ways of tracking launch progress through management dashboards for pharmaceutical clients, and identifying better ways to leverage internal information. Natalie then moved to oncology consulting at IMS where she was Business Development Manager, EMEA.
Natalie holds a BSc in molecular cell biology and an MSc in oncology from the University of Nottingham. She is fluent in French.
Neil Johnson, one of the founding Directors of RJW & Partners said: “We are delighted to welcome Natalie to the team. Her therapeutic area expertise is coupled with solid consulting experience and she has a proven commitment to delivering high quality strategic insights to clients. Natalie will be a considerable asset to our business delivery and development”.
RJW & Partners offer a complete suite of services spanning every stage of the product lifecycle including: pricing and market access strategy development, support planning and audit, global and affiliate strategy implementation, the evaluation of new in or out-licensing opportunities and organisational development and improvement. At the core of each assignment is the wish to make a meaningful and commercially tangible contribution to the development of the client’s business.
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- GSK injects $60 million and 58 jobs into Victoria (6 February 2012)
- Merck provides update on development program for Suvorexant (6 February 2012)
- Novartis drug Galvus® approved in EU for monotherapy use in patients with type 2 diabetes unable to take metformin (6 February 2012)
- Tecan and Artel partner to produce unique, fully integrated QC Kit for Freedom EVO® workstations (6 February 2012)
- Expiration of the Hart-Scott-Rodino waiting period for acquisition of Inhibitex, Inc. (3 February 2012)
PAT supplement
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
Company directory
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Synbiosis | Syngene | Watson-Marlow Pumps Group |
Login to access exclusive content